Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
Abstract Cutaneous and Head and Neck squamous cell carcinoma (CSCC, HNSCC) are among the most prevalent cancers. Both types of cancer can be treated with photodynamic therapy (PDT) by using the photosensitizer Temoporfin in HNSCC and the prodrug methyl-aminolevulinate (MAL) in CSCC. However, PDT is...
Main Authors: | J. Nicolás-Morala, M. Alonso-Juarranz, A. Barahona, S. Terrén, S. Cabezas, F. Falahat, Y. Gilaberte, S. Gonzalez, A. Juarranz, M. Mascaraque |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-57624-8 |
Similar Items
-
The Distinctive Features behind the Aggressiveness of Oral and Cutaneous Squamous Cell Carcinomas
by: Miguel Alonso-Juarranz, et al.
Published: (2023-06-01) -
Biomarkers of basal cell carcinoma resistance to methyl-aminolevulinate photodynamic therapy.
by: Tamara Gracia-Cazaña, et al.
Published: (2019-01-01) -
Photodynamic Therapy (PDT) in Oncology
by: Ángeles Juarranz, et al.
Published: (2020-11-01) -
Metformin overcomes metabolic reprogramming-induced resistance of skin squamous cell carcinoma to photodynamic therapy
by: Marta Mascaraque-Checa, et al.
Published: (2022-06-01) -
TGFβ1 Secreted by Cancer-Associated Fibroblasts as an Inductor of Resistance to Photodynamic Therapy in Squamous Cell Carcinoma Cells
by: María Gallego-Rentero, et al.
Published: (2021-11-01)